HB 2200 (Robinson) deals with BPOL taxes for oncology practices and would require a deduction from gross receipts for any amount paid for anti-cancer drugs that are purchased by a medical practice and administered to patients whose treatment is paid for by Medicare, Medicaid, or TRICARE. VACo is opposed to a mandatory approach to tax relief for these businesses.
Although the proponents of the legislation intend to address a specific type of business and provide for a narrow carveout, the legislation sets a precedent for other types of businesses seeking similar exemptions in the future. VACo has encouraged proponents of the legislation to explore existing regulatory authority available to localities to establish subclassifications within the existing BPOL business categories and impose taxes at lower rates on businesses within such subclassifications.
The legislation was heard in subcommittee on Monday afternoon and recommended to be reported. The full House Finance Committee will likely take up the measure on Wednesday, February 1.
Please encourage members of the House Finance Committee to amend this legislation to provide for a local option or to vote against the bill in its current form.
Members of House Finance: Robinson (Chair), Fowler (Vice Chair), Orrock, Ware, Byron, Freitas, McNamara, Walker, Runion, Wiley, Durant, Greenhalgh, Watts, Sullivan, Murphy, Hudson, Willett, Scott, D.L., Mundon King, Simon, Bennett-Parker, Convirs-Fowler
VACo Contact: Katie Boyle